News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Kopczynski Casey C.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/21/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Disposed/sold 280,244 shares
@ $15.25, valued at
$4.3M
Disposed/sold 25,000 options to buy
@ $3.15, valued at
$78.8k
Disposed/sold 65,941 options to buy
@ $8.8, valued at
$580.3k
|
|
03/22/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Granted 19,015 shares
@ $0 Granted 65,941 options to buy
@ $8.8, valued at
$580.3k
|
|
02/09/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 701 shares
@ $7.24, valued at
$5.1k
Paid exercise price by delivering 700 shares
@ $7.33, valued at
$5.1k
|
|
02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2020 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 7,305 shares
@ $13, valued at
$95k
Sold 22,695 shares
@ $13.0077, valued at
$295.2k
|
|
02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/05/2019 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Exercised 117,000 options to buy
@ $0.405, valued at
$47.4k
|
|
02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/02/2019 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 11,000 shares
@ $35.2103, valued at
$387.3k
|
|
12/04/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 10,701 shares
@ $39.7879, valued at
$425.8k
Sold 299 shares
@ $40.5464, valued at
$12.1k
|
|
11/02/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 25 shares
@ $52.55, valued at
$1.3k
Sold 3,208 shares
@ $52.9936, valued at
$170k
Sold 7,792 shares
@ $54.2245, valued at
$422.5k
Exercised 3,251 options to buy
@ $0.395, valued at
$1.3k
|
|
10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/06/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 10,000 shares
@ $60.0024, valued at
$600k
Sold 1,000 shares
@ $61, valued at
$61k
|
|
08/02/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 6,210 shares
@ $68.0024, valued at
$422.3k
Sold 4,790 shares
@ $68.6854, valued at
$329k
|
|
07/05/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 8,400 shares
@ $66.1457, valued at
$555.6k
Sold 2,600 shares
@ $67.0923, valued at
$174.4k
|
|
06/08/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Sold 8,000 shares
@ $58.5744, valued at
$468.6k
Sold 3,000 shares
@ $59.2138, valued at
$177.6k
|
|
05/29/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 292 shares
@ $50.41, valued at
$14.7k
Sold 2,708 shares
@ $50.15, valued at
$135.8k
Exercised 3,000 warrants
@ $5, valued at
$15k
|
|
05/10/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 331 shares
@ $53.85, valued at
$17.8k
Paid exercise price by delivering 674 shares
@ $53.85, valued at
$36.3k
Paid exercise price by delivering 539 shares
@ $53.85, valued at
$29k
|
|
02/12/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Granted 8,000 shares
@ $0 Granted 36,000 options to buy
@ $53.55, valued at
$1.9M
|
|
02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/01/2013 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Converted 18,651 shares
@ $0 Converted 3,000 warrants
@ $0 Converted 18,651 options to buy
@ $0 |
|
|
|